Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer

Prostate

Volumn 63, Issue 4, 2005, Pages 309-315

  Binnie, Margaret C ^a   Alexander, Freda E ^b   Heald, Charlotte ^b   Habib, Fouad K ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

CAG and GGC repeat; Prostate cancer risk; PSA ARE genotype; SNP

Indexed keywords

ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN; RESTRICTION ENDONUCLEASE;

ADULT; ALLELE; ARTICLE; CANCER GENETICS; CANCER RISK; CONTROLLED STUDY; DNA EXTRACTION; FLUORESCENCE; GENE AMPLIFICATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE HYPERTROPHY; TRINUCLEOTIDE REPEAT;

AGED; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REGISTRIES; RESPONSE ELEMENTS; RISK FACTORS; TRINUCLEOTIDE REPEATS;

EID: 18644369908     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20178     Document Type: Article

References (34)

1. Dearnley DP. Current issues in cancer - Cancer of the prostate. 2. Br Med J 1994;308:780-784.
2. Coetzee GA, Ross RK. Prostate cancer and the androgen receptor. J Natl Cancer Inst 1994;86:872-873.
3. Sleddens HFBM, Oostra BA, Brinkmann AO, Trapman J. Trinucleotide repeat polymorphism in the androgen receptor. Nucleic Acids Res 1992;20:1427.
4. Kazemiesfarjani P, Trifro MA, Pinsky L. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor - Possible pathogenic relevance for the (CAG)(N) expanded neuronopathies. Hum Mol Genet 1995;4:523-527.
5. Sleddens HFBM, Oostra BA, Brinkmann AO, Trapman J. Trinucleotide (GNN) repeat polymorphism in the human androgen receptor (AR) gene. Hum Mol Genet 1993;2:493.
6. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Brufsky A, Talcott J, Hennekens CH, Kantoff PW. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 1997;94:3320-3323.
7. Hsing AW, Gao Y, Wu G, Wang X, Deng J, Chen Y, Sesterhenn IA, Mostofe FK, Benichou J, Chang C. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: A population-based case-control study in China. Cancer Res 2000;60:5111-5116.
8. Suzuki H, Akakura K, Komiya A, Ueda T, Imamoto T, Furuya Y, Ichikawa T, Watanabe M, Shiraishi T, Ito H. CAG polymorphic repeat lengths in the androgen receptor gene among Japanese prostate cancer patients: Potential predictor of prognosis after endocrine therapy. Prostate 2002;51:219-224.
9. Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA, Ostrander EA. Polymorphic repeats in the androgen receptor gene: Molecular markers of prostate cancer risk. Cancer Res 1997;57:1194-1198.
10. Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 1995;55:1937-1940.
11. Edwards SM, Badzioch MD, Minter R, Hamoudi R, Collins N, Arden-Jones A, Dowe A, Osbourne S, Kelly J, Shearer R, Eastom DF, Saunders GF, Dearnley DP, Eeles RA. Androgen receptor polymorphisms: Association with prostate cancer risk, relapse, and overall survival. Int J Cancer 1999;84:458-465.
12. Hakimi JM, Schoenberg MP, Rondinelli RH, Piantadosi S, Barrack ER. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res 1997;3:1599-1608.
13. Chang BL, Zheng SL, Hawkins GA, Issacs SD, Wiley KE, Turner A, Carpten JD, Bleecker ER, Walsh PC, Trent JM, Meyers DA, Isaacs WB, Xu J. Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk. Hum Genet 2002;110:122-129.
14. Buchanan G, Irvine RA, Coetzee GA, Tilley WD. Contribution of the androgen receptor to prostate cancer predisposition and progression. Cancer Metastasis Rev 2001;20:207-223.
15. nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Eur J Hum Genet 1999;7:357-362.
16. Lange E, Chen H, Brierley K, Livermore H, Wojno KJ, Langefeld CD, Lange K, Cooney KA. The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer. Cancer Epidemiol Biomarkers Prev 2000;9:439-442.
17. Mir K, Edwards J, Paterson PJ, Hehir M, Underwood MA, Bartlett JMS. The CAG trinucleotide repeat length in the androgen receptor does not predict the early onset of cancer. BJU 2002;90:573-578.
18. Armbruster DA. Prostate-specific antigen: Biochemistry, analytical methods, and clinical application. Clin Chem 1993;39:181-195.
19. Aziz DC, Barathur RB. Prostate-specific antigen and prostate volume - A metaanalysis of prostate cancer screening criteria. J Clin Lab Anal 1993;7:283-292.
20. Xue W, Irvine RA, Yu MC, Ross RK, Coetzee GA, Ingles SA. Susceptibility to prostate cancer: Interaction between genotypes at the androgen receptor and prostate-specific androgen loci. Cancer Res 2000;60:839-841.
21. Henderson RJ, Eastman JA, Culkin DJ, Kuttan MW, Whatley T, Mut J, Venable D, Sartar D. Prostate specific androgen (PSA) & PSA density: Racial differences in men without prostate cancer. J Natl Cancer Inst (Bethesda) 1997;89:134-138.
22. Yang Q, Shan L, Segawa N, Nakamura M, Nakamura Y, Mori I, Sakuri T, Katudo K. Novel polymorphisms in prostate specific antigen gene and its association with prostate cancer. Anticancer Res 2001;21:197-200.
23. Xu J, Meyers DA, Sterling DA, Zheng SL, Catalona WJ, Cramer SD, Bleecker ER, Ohar J. Association studies of serum prostate specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate specific antigen genes. Cancer Epidemiol Biomarkers Prev 2002;11:664-669.
24. Ruijter E, Van De Kaa C, Miller G, Ruiter D, Debruyne F, Schalken J. Molecular genetics and epidemiology of prostate carcinoma. Endocrine Rev 1999;20:22-45.
25. Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA. Association of prostate cancer risk with polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997;89:166-170.
26. Hardy DO, Scher HI, Bogenreider T, Sabbatini P, Zhang Z, Nanus DM, Catterall JF. Androgen receptor CAG repeat lengths in prostate cancer: Correlation with age of onset. J Clin Endocrinol Metab 1996;81:4400-4405.
27. Bratt O, Borg A, Kristoffersson U, Lundgren R, Zhang Q-K, Olsson H. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk. Br J Cancer 1999;81:672-676.
28. Nam RK, Elhaji Y, Krahn MD, Hakami J, Ho M, Chu W, Sweet J, Trachtenberg J, Jewett MA, Narod SA. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression. J Urol 2000;164:567-572.
29. Platz EA, Giovannucci E, Dajl DM, Krithivas K, Hennekens CH, Brown M, Stampfer MJ, Kantoff PW. The androgen receptor gene GGN microsatellite and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:379-384.
30. Ross RK, Reichardt JKV, Ingles SA, Coetzee GA. The genetic epidemiology of prostate cancer, closing in on a complex disease. In: Leland Chung, William Isaacs, Jonathan Simons, editors. Prostate cancer: Biology, genetics, and the new therapeutics. Totowa, NJ: Humana Press, 2001. pp 111-121.
31. Rao A, Cramer SD. Identification of a polymorphism in the ARE 1 region of the PSA promoter. Proc Am Assoc Cancer Res 1999;40:65.
32. Maderios R, Morias A, Vasconcelos A, Costa S, Pinto D, Oliveira J, Carvalho R, Lopes C. Linkage between polymorphisms in the prostate specific antigen ARE 1 gene region, prostate cancer risk and circulating tumor cells. Prostate 2002;53:88-94.
33. Xue W, Coetzee GA, Ross RK, Irvine R, Kolonel L, Henderson BE, Ingles SA. Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2001;10:575-579.
34. Cramer SD, Chang B-L, Rao A, Hawkins GA, Zheng SL, Wade WN, Cooke RT, Thomas LN, Bleecker ER, Atalona WJ, Sterling DA, Meyers DA, Ohar J, Xu J. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels. J Natl Cancer Inst 2003;95:1044-1052.